by B2i | Nov 3, 2025 | Press Releases
Gaithersburg, Maryland–(Newsfile Corp. – November 3, 2025) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle Pharma” or the “Company”), today announced that it entered into a securities purchase agreement with...
by B2i | Oct 21, 2025 | Press Releases
Rockville, Maryland–(Newsfile Corp. – October 21, 2025) – Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) (“Shuttle” or the “Company”) today announced that it has entered into a binding term sheet with 1542770 BC Ltd....
by B2i | Oct 10, 2025 | Press Releases
GAITHERSBURG, Md., Oct. 10, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today announced the...
by B2i | Oct 9, 2025 | Press Releases
GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today announced the...
by B2i | Aug 14, 2025 | Press Releases
GAITHERSBURG, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving...
